Fengzhi Suo

发表

Development of formaldehyde dehydrogenase‐coupled assay and antibody‐based assays for ALKBH5 activity evaluation

Hong-min Liu, Dandan Shen, Yichao Zheng, 2019, Journal of pharmaceutical and biomedical analysis.

Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.

Xiaojuan Wang, Xiaoyu Zhai, Hongmin Liu, 2018, Bioorganic & medicinal chemistry.

Lysine‐specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC‐803

Hong-min Liu, Yichao Zheng, Fengzhi Suo, 2018, Journal of cellular biochemistry.

Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.

Hong-min Liu, K. Sun, Yichao Zheng, 2017, Bioorganic & medicinal chemistry letters.

Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors.

Hong-min Liu, Bin Yu, Yichao Zheng, 2017, ACS medicinal chemistry letters.

Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation.

Hong-min Liu, Bin Yu, Li-Juan Zhao, 2020, Bioorganic chemistry.

Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors.

Hong-min Liu, Bin Yu, Shuai Wang, 2019, European journal of medicinal chemistry.

Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors.

Linlin Yang, Hong-min Liu, Bin Yu, 2019, European journal of medicinal chemistry.

Identification of osimertinib (AZD9291) as a lysine specific demethylase 1 inhibitor.

Dongjun Fu, Hong-min Liu, Bin Yu, 2019, Bioorganic chemistry.

Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)

Lina Ding, Liying Ma, Hongmin Liu, 2019, Acta pharmaceutica Sinica. B.

Artemisinin-Type Drugs in Tumor Cell Death: Mechanisms, Combination Treatment with Biologics and Nanoparticle Delivery

W. Quax, Xinyu Zhou, Fengzhi Suo, 2022, Pharmaceutics.

USP28 contributes to the proliferation and metastasis of gastric cancer

Y. Liu, Hong-min Liu, Li-Juan Zhao, 2018, Journal of cellular biochemistry.

Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors.

Hong-min Liu, Yichao Zheng, Fengzhi Suo, 2019, European journal of medicinal chemistry.

An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors.

Hong-min Liu, Y. Liu, Xiao-Bing Chen, 2017, Current medicinal chemistry.

Sanggenon O induced apoptosis of A549 cells is counterbalanced by protective autophagy.

Hong-min Liu, M. Mamun, Yichao Zheng, 2019, Bioorganic chemistry.

Artemisinin-Type Drugs in Tumor Cell Death: Mechanisms, Combination Treatment with Biologics and Nanoparticle Delivery

W. Quax, Xinyu Zhou, Fengzhi Suo, 2022, Pharmaceutics.